Advertising
Showing 1 to 15 of 42 entries
BUY

Happy to own this, outperforming XLV, for instance. It's diversified. ZUH is another option, because it covers pharmas, hospital management and other areas. IHI, as a hospital provider, is pretty good.

E.T.F.'s
BUY

Not overly bullish on healthcare as a whole, as its growth may be less attractive. Likes medical devices, with a built-in backlog due to Covid. He owns SYK. There should be a significant pickup in procedures over the next 2 years. SYK has strong earnings growth, near a 1-year high. Also look at IHI, the medical devices ETF, packed with companies leading the healthcare sector.

E.T.F.'s
PARTIAL SELL
This ETF has smashed it over the past 5 years. Medical devices are a hybrid of tech and healthcare, which he really likes. Problem is that market enthusiasm and growth are priced in here already (like the FAANGs). Take profits.
E.T.F.'s
BUY
It specializes in medical devices and equipment. He has held this over a year and a half. He likes the diversification it offers. He is not sure which of the holdings are involved in manufacturing defibrillators.
E.T.F.'s
DON'T BUY
It's very nichy, though it offers good exposure to healthcare. It's a high-beta play on healthcare, biotech and medical devices. His main worry is uncertainty around the US election, namely Bernie Sanders. If he nationalizes medical care, then this ETF will suffer.
E.T.F.'s
BUY
He likes medical devices a lot. The ETF looks good with reasonable MER. Once the rhetoric from the presidential campaign subsides, it’ll probably have more smooth sailing.
E.T.F.'s
PAST TOP PICK
(A Top Pick Oct 16/18, Up 16%) It continues to work. Everything is going right with this one. It is not a defensive name and while he likes it, he would not have more than a few percent of it in the market.
E.T.F.'s
TOP PICK
He loves it. It was flat over the last quarter. He is sticking with it.
E.T.F.'s
PAST TOP PICK

(A Top Pick Aug 15/18, Up 20%) A good way to play pharma without the litigation problems. For a Canadian one, it would be ZUH. Medical devices have done very well, and wish he had more.

E.T.F.'s
TOP PICK
A perennial favorite for him. Worldwide hospital spending, global spending and Type II diabetes on the rise all make this a good holding. It is fairly high beta, so if the market falls this will fall too. Yield 0.31%
E.T.F.'s
TOP PICK
The only area of healthcare he remains invested in. The demographics are creating tailwinds. An aging population and growing obesity is good for this. Good cash flow holdings and good diversification. Yield 0.32%
E.T.F.'s
PAST TOP PICK
(A Top Pick Jul 11/18, Up 19%) A great example of demographic and diabetes trends that has created huge growth in demand. A sad, but profitable story. Not a defensive stock and has beta with the market.
E.T.F.'s
PAST TOP PICK
(A Top Pick Jun 08/18, Up 11%) He continues to love holding this. Worldwide hospital spending continues to increase.
E.T.F.'s
BUY
He likes this. Medical devices play to an aging demographic. The risk is political intereference with governments issuing new laws that interfere with this sector.
E.T.F.'s
PAST TOP PICK
(A Top Pick May 09/18, Up 16%) He sees this continuing to be a good performer. It will follow the market up and down, but will do a little better in the long run. The ETF helps reduce the risk of picking a single company. He has backed away from healthcare, but still still holds this.
E.T.F.'s
Showing 1 to 15 of 42 entries

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 3

Stockchase rating for ISHARES DOW JONES US MEDICAL DEV.(ETF) is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N) Frequently Asked Questions

What is ISHARES DOW JONES US MEDICAL DEV.(ETF) stock symbol?

ISHARES DOW JONES US MEDICAL DEV.(ETF) is a American stock, trading under the symbol IHI-N on the NYSE Arca (IHI). It is usually referred to as AMEX:IHI or IHI-N

Is ISHARES DOW JONES US MEDICAL DEV.(ETF) a buy or a sell?

In the last year, 3 stock analysts published opinions about IHI-N. 2 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for ISHARES DOW JONES US MEDICAL DEV.(ETF).

Is ISHARES DOW JONES US MEDICAL DEV.(ETF) a good investment or a top pick?

ISHARES DOW JONES US MEDICAL DEV.(ETF) was recommended as a Top Pick by on . Read the latest stock experts ratings for ISHARES DOW JONES US MEDICAL DEV.(ETF).

Why is ISHARES DOW JONES US MEDICAL DEV.(ETF) stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is ISHARES DOW JONES US MEDICAL DEV.(ETF) worth watching?

3 stock analysts on Stockchase covered ISHARES DOW JONES US MEDICAL DEV.(ETF) In the last year. It is a trending stock that is worth watching.

What is ISHARES DOW JONES US MEDICAL DEV.(ETF) stock price?

On 2021-09-27, ISHARES DOW JONES US MEDICAL DEV.(ETF) (IHI-N) stock closed at a price of $64.71.